September 28, 2014 | The Israeli biomedical investment company Trendlines Group filed a prospectus with securities regulatory authorities in Canada. The company filed with authorities in Ontario, British Columbia, Alberta, Saskatchewan, Manitoba and Nova Scotia, with plans to sell over 2 million shares at C$3.60 (US$3.23) a share at a company value of C$80 million after money (US$71.7 million). The company hopes to raise C$9.5 million (US$8.5 million) in the offering, and most of the shares have already been allocated. The offer is set to close on September 30th, after the IPO was delayed due to Operation Protective Edge. Trendlines Group was founded in 2004 by Todd Doloinger and Steve Rhodes, American immigrants to Israel that began their company as a business consulting service for medical companies, which expanded to the agritech sector.